How big is the U.S. vaccines market?

The U.S. vaccines market size was valued at USD 26.0 billion in 2025 and is anticipated to reach USD 27.82 billion in 2026.

What is the U.S. vaccines market growth?

The U.S. vaccines market is expected to witness a compound annual growth rate of 5.4% from 2026 to 2033 to reach USD 40.19 billion by 2033.

Which segment accounted for the largest U.S. vaccines market share?

Based on indication, the viral vaccines segment dominated the market with the largest revenue share of 64.67% in 2025, driven by sustained demand for vaccines targeting influenza, COVID-19, RSV, and other infectious viral diseases..

Who are the key players in U.S. vaccines market?

Some of the key players in U.S. vaccines market are Pfizer , GSK , Merck & Co. (MSD) , Sanofi , and Moderna

What are the factors driving the U.S. vaccines market?

The U.S. vaccines market is driven by rapid advancements in vaccine technologies and platform innovation. The adoption of mRNA, recombinant, and vector-based approaches is accelerating the development of more effective and targeted vaccines across multiple disease areas..